Triasima Portfolio Management inc. Sells 753 Shares of Axon Enterprise, Inc (NASDAQ:AXON)

Triasima Portfolio Management inc. lessened its holdings in Axon Enterprise, Inc (NASDAQ:AXON) by 9.2% during the 1st quarter, HoldingsChannel reports. The firm owned 7,448 shares of the biotechnology company’s stock after selling 753 shares during the period. Triasima Portfolio Management inc.’s holdings in Axon Enterprise were worth $3,917,000 at the end of the most recent reporting period.

Several other large investors also recently bought and sold shares of AXON. Fourth Dimension Wealth LLC bought a new stake in Axon Enterprise in the fourth quarter worth $30,000. Bartlett & CO. Wealth Management LLC increased its position in Axon Enterprise by 132.0% during the first quarter. Bartlett & CO. Wealth Management LLC now owns 58 shares of the biotechnology company’s stock valued at $31,000 after acquiring an additional 33 shares during the last quarter. Catalyst Capital Advisors LLC bought a new position in Axon Enterprise during the first quarter valued at $32,000. Alpine Bank Wealth Management bought a new position in Axon Enterprise during the first quarter valued at $40,000. Finally, Elequin Capital LP bought a new position in Axon Enterprise during the fourth quarter valued at $46,000. Institutional investors own 79.08% of the company’s stock.

Insider Buying and Selling at Axon Enterprise

In other news, President Joshua Isner sold 905 shares of the firm’s stock in a transaction that occurred on Tuesday, June 17th. The shares were sold at an average price of $776.39, for a total transaction of $702,632.95. Following the sale, the president owned 268,735 shares of the company’s stock, valued at $208,643,166.65. This trade represents a 0.34% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, CRO Cameron Brooks sold 3,000 shares of Axon Enterprise stock in a transaction on Friday, May 30th. The shares were sold at an average price of $740.76, for a total transaction of $2,222,280.00. Following the completion of the sale, the executive directly owned 19,447 shares in the company, valued at $14,405,559.72. This represents a 13.36% decrease in their position. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 44,642 shares of company stock worth $30,500,428. 5.70% of the stock is currently owned by insiders.

Analysts Set New Price Targets

A number of research analysts have recently commented on AXON shares. Morgan Stanley set a $885.00 price target on shares of Axon Enterprise and gave the stock an “overweight” rating in a report on Friday. Bank of America upped their price target on shares of Axon Enterprise from $750.00 to $895.00 and gave the stock a “buy” rating in a report on Wednesday, June 4th. Barclays upped their price target on shares of Axon Enterprise from $726.00 to $735.00 and gave the stock an “overweight” rating in a report on Friday, May 9th. Needham & Company LLC increased their target price on shares of Axon Enterprise from $600.00 to $750.00 and gave the stock a “buy” rating in a report on Thursday, May 8th. Finally, The Goldman Sachs Group increased their price target on shares of Axon Enterprise from $730.00 to $830.00 and gave the company a “buy” rating in a research report on Wednesday, May 14th. One research analyst has rated the stock with a sell rating, two have assigned a hold rating and eleven have issued a buy rating to the company’s stock. According to MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average price target of $725.00.

Axon Enterprise Price Performance

Shares of NASDAQ:AXON opened at $745.87 on Wednesday. Axon Enterprise, Inc has a twelve month low of $279.02 and a twelve month high of $830.21. The company’s 50 day moving average is $758.11 and its 200 day moving average is $642.83. The company has a current ratio of 2.83, a quick ratio of 2.62 and a debt-to-equity ratio of 0.68. The company has a market cap of $58.07 billion, a PE ratio of 180.16, a price-to-earnings-growth ratio of 86.36 and a beta of 1.29.

Axon Enterprise (NASDAQ:AXON) last issued its quarterly earnings results on Wednesday, May 7th. The biotechnology company reported $1.41 earnings per share for the quarter, topping the consensus estimate of $1.34 by $0.07. Axon Enterprise had a net margin of 14.86% and a return on equity of 5.81%. The company had revenue of $603.63 million for the quarter, compared to the consensus estimate of $585.67 million. During the same quarter in the prior year, the company earned $1.15 EPS. Axon Enterprise’s quarterly revenue was up 31.3% on a year-over-year basis. On average, sell-side analysts forecast that Axon Enterprise, Inc will post 5.8 EPS for the current year.

Axon Enterprise Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.